MedPath

Psychological and Enterostomal Therapy Care

Not Applicable
Conditions
Cancer of Rectum
Registration Number
NCT01403883
Lead Sponsor
Association de Recherche Experimentale et Clinique en Chirurgie Digestive
Brief Summary

In case of rectal cancer surgery, temporary stoma is recommended to decrease the risk of postoperative anastomotic leakage. The aim of the study was to assess the benefit of an optimal care, i.e., both psychological and enterostomal therapy care.

Detailed Description

The aim of the study is to asses the benefit of an optimal and specific care concerning the temporary stoma in patients operated for rectal cancer surgery in term of psychological and enterostomal therapy effect.

This study is a monocentric and randomized trial.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Age > 18 y
  • Rectal adenocarcinoma (tumor height < 15 cm from the anal verge) with or without pre operative radiochemotherapy.
  • Open or laparoscopic rectal excision with partial or total meso rectal excision with sphincter preservation by colo rectal or colo anal anastomosis.
  • Temporary stoma.
  • Patient consent
  • Patient with national health affiliation
Exclusion Criteria
  • Stage IV disease with synchronous hepatic or pulmonary metastases
  • Colonic cancer > 16 cm
  • Associated surgical procedure (Hepatic resection, small bowel resection subtotal colectomy)
  • Abdominal perineal resection
  • Associated comorbidity
  • Emergency surgery
  • Psychological care refusal

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Evolution of Psychological anxiety score (STAI/Beck)at Day-45, Day0, Day45, Day60, Day90
Evolution of Global Quality of life (SF36)at Day45, Day0, Day45, Day60, Day90
Secondary Outcome Measures
NameTimeMethod
Evolution of Specific stoma score and stoma care learningat Day-45, Day0, Day45, Day60, Day90
Hospital stayat Day90
Overall morbidityat Day45, Day60, Day90
Specific stoma related morbidityat Day45, Day60, Day90

Trial Locations

Locations (1)

Hôpital Beaujon

🇫🇷

Clichy, France

Hôpital Beaujon
🇫🇷Clichy, France
Frederic Bretagnol, PhD-MD
Contact
frederic.bretagnol@bjn.aphp.fr
Frédéric Bretagnol, PhD-MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.